NEW YORK (
( BGP) was in the limelight among small-cap stocks Friday, shooting up 14% to 92 cents on
reports that the company was close to securing financing..
In December, the book retailer said it would delay payments to publishers and distributors, triggering concerns about its financial health. Hedge fund manager
offered to finance Borders' bid of $963 million for
Barnes & Noble
Over 4 million shares were changing hands on Friday morning trading.
was among the top gainers in the small-cap category, bucking the trend in the healthcare space. The stock was surging 24.5% to $7.06 after it received regulatory approval for a new formulation of its Acetadote injection used to treat acetaminophen poisoning.
was zooming 21% to $16.36 after Piper Jaffrey issued a positive outlook for the company amid a super cycle in chip equipment.
were soaring for the second consecutive day, rising 12% to $2.80 on investor optimism about the prospects for the company's insulin drug, Linjeta. The stock gained 28% on Thursday, as the company made a presentation at the JPMorgan Healthcare Conference. Volumes were higher than average at 3.5 million shares.
gained 8% to $5.13 after
RBC Markets upgraded the stock by two notches to outperform. The analyst said the return of its former CEO Jack Massimino would help turnaround the company.
Other gainers include
, up 20% to $1.59,
, up 18% to $3.70 and
, up 12% at $1.28.
--Written by Shanthi Bharatwaj in New York
>To contact the writer of this article, click here:
>To follow the writer on Twitter, go to
>To submit a news tip, send an email to:
Disclosure: TheStreet's editorial policy prohibits staff editors and reporters from holding positions in any individual stocks.